Field Trip And Wesana Make Major Moves | FTRP, WESA

PSYCBiz
May 9, 2022
10:32 pm

Dyne’s $305M offering; Nanobiotix delays Ph2 readout

Dyne Therapeutics expects to net $305M in stock sale: The company on Monday dropped updated stock-moving results for its myotonic dystrophy type 1 and Duchenne

May 23, 2024

Deforestation drives a surge in malaria cases in the Amazon

Deforestation in the Brazilian Amazon is linked to a rise in malaria cases, with a 1% increase in deforestation leading to a 6.3% spike in

October 24, 2024

Wearable tech reveals: Social constructs and physical activity shape global sleep patterns

Researchers analyze sleep data from wearable devices to assess sleep patterns. Societal factors influence sleep quality and quantity, with exercise playing a positive role. Understanding

June 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.